These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4061686)

  • 21. The cortisol suppression index and the dexamethasone suppression test in major depression.
    Maes M; De Ruyter M; Suy E
    Acta Psychiatr Belg; 1987; 87():633-9. PubMed ID: 3452982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced cortisol suppression to dexamethasone associated with Gulf War deployment.
    Golier JA; Schmeidler J; Legge J; Yehuda R
    Psychoneuroendocrinology; 2006 Nov; 31(10):1181-9. PubMed ID: 17049422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortisol secretion and dexamethasone response in depression.
    Asnis GM; Sachar EJ; Halbreich U; Nathan RS; Ostrow L; Halpern FS
    Am J Psychiatry; 1981 Sep; 138(9):1218-21. PubMed ID: 7270728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo.
    Huizenga NA; Koper JW; De Lange P; Pols HA; Stolk RP; Burger H; Grobbee DE; Brinkmann AO; De Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1998 Jan; 83(1):144-51. PubMed ID: 9435432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age, medical illness, and the DST in depressed general hospital inpatients.
    Fogel BS; Satel SL
    J Clin Psychiatry; 1985 Mar; 46(3):95-7. PubMed ID: 3972780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of human lymphocytes to antiproliferative effects of glucocorticoids and effectiveness of reception].
    Kalashnikova EA; Pukhal'skiĭ AL; Liashko VN
    Biull Eksp Biol Med; 1989 Nov; 108(11):583-4. PubMed ID: 2633823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone effects on numbers of cells in lymphocyte subpopulations: changes associated with major depression and DST nonsuppression.
    Pedersen CA; Folds JD; Evans DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):895-906. PubMed ID: 2813807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte glucocorticoid receptor binding in depression: normal values following recovery.
    Hunter R; Dick H; Christie JE; Goodwin GM; Fink G
    J Affect Disord; 1988; 14(2):155-9. PubMed ID: 2966829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone suppression tests in patients with obsessive-compulsive disorder.
    Lieberman JA; Kane JM; Sarantakos S; Cole K; Howard A; Borenstein M; Novacenko H; Puig-Antich J
    Am J Psychiatry; 1985 Jun; 142(6):747-51. PubMed ID: 4003598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone suppression in major depression.
    Kocsis JH; Brockner N; Butler T; Fanelli C; Stokes PE
    Biol Psychiatry; 1984 Aug; 19(8):1255-9. PubMed ID: 6498246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between serum cortisol, liver function, and depression in detoxified alcoholics.
    Zern MA; Halbreich U; Bacon K; Galanter M; Kang BJ; Gasparini F
    Alcohol Clin Exp Res; 1986 Jun; 10(3):320-2. PubMed ID: 3526957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression.
    Maes M; De Ruyter M; Hobin P; Suy E
    Psychiatry Res; 1987 Aug; 21(4):323-35. PubMed ID: 3628615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mitogen concentration on glucocorticoid suppression of normal and cystic fibrosis lymphocyte activation.
    Distelhorst CW; Benutto BM; Corry JM
    Cell Immunol; 1983 Jan; 75(1):188-92. PubMed ID: 6825183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte function in major depressive disorder.
    Schleifer SJ; Keller SE; Meyerson AT; Raskin MJ; Davis KL; Stein M
    Arch Gen Psychiatry; 1984 May; 41(5):484-6. PubMed ID: 6609689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy.
    Reder AT; Lowy MT; Meltzer HY; Antel JP
    Neurology; 1987 May; 37(5):849-53. PubMed ID: 3033547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid receptor binding in three different cell types in major depressive disorder: lack of evidence of receptor binding defect.
    Wassef AA; O'Boyle M; Gardner R; Rose RM; Brown A; Harris A; Nguyen H; Meyer WJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):65-78. PubMed ID: 1557508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.